Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.470
+0.050 (3.52%)
At close: Mar 10, 2026, 4:00 PM EDT
1.470
0.00 (0.00%)
After-hours: Mar 10, 2026, 4:10 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $103.93 million as of March 10, 2026. Its market cap has decreased by -17.11% in one year.
Market Cap
103.93M
Enterprise Value
65.58M
1-Year Change
-17.11%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $103.93M, a decrease of -78.75%. That is a compound annual growth rate of -27.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 100.40M | 14.52% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | 489.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 105.29M |
| Fortress Biotech | 103.67M |
| Turn Therapeutics | 103.06M |
| Agenus | 100.66M |
| Seer, Inc. | 100.43M |
| Cassava Sciences | 98.07M |
| Dogwood Therapeutics | 96.22M |
| Anixa Biosciences | 95.13M |